A clinical trial to investigate the safety and effectiveness of a new insulin (INS068) when used in combination with oral medications to manage type 2 diabetes.
About this study
The purpose of this research study is to:
- Test the safety and effectiveness of the study drug, INS068
- Compare the study drug (INS068) to insulin degludec (Tresiba®)
Anticipated enrolment close date:
Who can take part
You may be eligible to take part in this study if:
- You have been diagnosed with type 2 diabetes
- You are aged between 18 and 75 years
- Your blood glucose levels could be better
- You do not currently administer your diabetes medication via an injection
What's involved
- Blood and urine samples
- Electrocardiograms (ECGs)
- Height and weight
- Blood pressure
Ethics
All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.
This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.
The Clinical Trials Centre (CTC) is a dedicated, purpose-built space where we conduct clinical trials.
The CTC is located on Level 2 South. When you arrive, if you are unsure where to go, talk to one of our friendly volunteers or the information desk staff.